VIM and polyostotic fibrous dysplasia: Immunostaining revealed that there was significantly decreased expression of GSC-related factors, including GLI1, SOX2, and vimentin in the background of PFD treatment, but residual tumor in TMZ treatment group still exhibited the expression of those proteins.